Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDResmed Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 9 | $2.73 | $2.85 | $2.80 |
| Q2 2026 | 9 | $2.86 | $2.93 | $2.89 |
| Q3 2026 | 8 | $2.80 | $2.89 | $2.87 |
| Q4 2026 | 6 | $3.05 | $3.15 | $3.09 |
| Q1 2027 | 3 | $3.06 | $3.17 | $3.11 |
| Q2 2027 | 5 | $3.13 | $3.23 | $3.17 |
| Q3 2027 | 3 | $3.13 | $3.23 | $3.17 |
| Q4 2027 | 6 | $3.37 | $3.49 | $3.42 |
| Q1 2028 | 4 | $3.41 | $3.52 | $3.46 |
| Q2 2028 | 6 | $3.48 | $3.60 | $3.53 |
Resmed Inc. Earnings Date And Information
Resmed Inc. last posted its earnings results on Thursday, April 30th, 2026. The company reported $2.86 earnings per share for the quarter, topping analysts' consensus estimates of $2.79 by $0.07. The company had revenue of 1.43 B for the quarter and had revenue of 5.15 B for the year. Resmed Inc. has generated $10 earnings per share over the last year ($9.51 diluted earnings per share) and currently has a price-to-earnings ratio of 20.27. Resmed Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Resmed Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/30/2026 | Q3 2026 | $2.79 | $2.72 | -0.07 | $1.42 B | $1.43 B |
| 01/29/2026 | Q2 2026 | N/A | $2.69 | N/A | $1.40 B | $1.42 B |
| 10/30/2025 | Q1 2026 | N/A | $2.38 | N/A | $1.33 B | $1.34 B |
| 08/07/2025 | Q4 2025 | N/A | $2.59 | N/A | $1.33 B | $1.35 B |
| 04/23/2025 | Q3 2025 | $2.38 | $2.49 | 0.11 | $1.29 B | $1.29 B |
| 01/30/2025 | Q2 2025 | N/A | $2.35 | N/A | $1.27 B | $1.28 B |
| 10/24/2024 | Q1 2025 | N/A | $2.12 | N/A | $1.19 B | $1.22 B |
| 08/08/2024 | Q4 2024 | N/A | $1.99 | N/A | $1.22 B | $1.22 B |
| 04/25/2024 | Q3 2024 | N/A | $2.04 | N/A | $1.17 B | $1.20 B |
| 01/24/2024 | Q2 2024 | N/A | $1.42 | N/A | N/A | $1.16 B |
| 10/26/2023 | Q1 2024 | N/A | $1.49 | N/A | N/A | $1.10 B |
| 08/10/2023 | Q4 2023 | N/A | $1.56 | N/A | N/A | $1.12 B |
| 04/27/2023 | Q3 2023 | N/A | $1.58 | N/A | N/A | $1.12 B |
| 01/26/2023 | Q2 2023 | N/A | $1.53 | N/A | N/A | $1.03 B |
| 10/27/2022 | Q1 2023 | N/A | $1.44 | N/A | N/A | $950.29 M |
| 08/11/2022 | Q4 2022 | N/A | $1.33 | N/A | N/A | $914.74 M |
| 04/28/2022 | Q3 2022 | N/A | $1.22 | N/A | N/A | $864.50 M |
| 01/27/2022 | Q2 2022 | N/A | $1.38 | N/A | N/A | $894.87 M |
| 10/28/2021 | Q1 2022 | N/A | $1.40 | N/A | N/A | $904.02 M |
| 08/16/2021 | Q4 2021 | N/A | $1.34 | N/A | N/A | $876.10 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Resmed Inc. Earnings: FAQ's
In the previous quarter, Resmed Inc. (:RMD) reported $2.86 earnings per share (EPS) to beat the analysts' consensus estimate of $2.79 by $0.07.
The conference call for Resmed Inc.'s latest earnings report can be listened to online.
The conference call transcript for Resmed Inc.'s latest earnings report can be read online.
Resmed Inc. (:RMD) has a recorded annual revenue of $5.15 B.
Resmed Inc. (:RMD) has a recorded net income of $1.40 B.Resmed Inc. has generated $9.55 earnings per share over the last four quarters.
Resmed Inc. (:RMD) has a price-to-earnings ratio of 20.27 and price/earnings-to-growth ratio is 1.27.